Intravenous flumazenil for Parkinson's disease: A double blind, placebo controlled, crossover trial.

被引：0
|
作者：
Ondo, WG [1 ]
Silay, YS [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MOVEMENT DISORDERS | 2004年 / 19卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1118 / 1119
页数：2
相关论文
共 50 条
  • [1] Intravenous flumazenil for Parkinson's disease: A single dose, double blind, placebo controlled, cross-over trial
    Ondo, William G.
    Silay, Yavuz S.
    MOVEMENT DISORDERS, 2006, 21 (10) : 1614 - 1617
  • [2] A double-blind, placebo-controlled single dose trial of intravenous flumazenil in Alzheimer's disease
    Templeton, L
    Barker, A
    Wesnes, K
    Wilkinson, D
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1999, 14 (04) : 239 - 245
  • [3] Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study
    Ravina, B
    Putt, M
    Siderowf, A
    Farrar, JT
    Gillespie, M
    Crawley, A
    Fernandez, HH
    Trieschmann, MM
    Reichwein, S
    Simuni, T
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (07): : 934 - 939
  • [4] BORNAPRINE VS PLACEBO IN PARKINSON DISEASE - DOUBLE-BLIND CONTROLLED CROSSOVER TRIAL IN 30 PATIENTS
    CANTELLO, R
    RICCIO, A
    GILLI, M
    DELSEDIME, M
    SCARZELLA, L
    AGUGGIA, M
    BERGAMASCO, B
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1986, 7 (01): : 139 - 143
  • [5] Melatonin on sleep in Parkinson's disease: A randomized double blind placebo controlled trial
    Sugumaran, Ramkumar
    Krishna, Kadarla Shiva Sai
    Saibaba, Jayaram
    Narayan, Sunil K.
    Sandhiya, S.
    Rajeswari, M.
    SLEEP MEDICINE, 2024, 124 : 502 - 509
  • [6] A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease
    Steele, IC
    Patterson, VH
    Nicholls, DP
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 136 (1-2) : 174 - 177
  • [7] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [8] Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double-blind placebo controlled trial
    Goetz, C. G.
    Damier, P.
    Hicking, C.
    Lasko, E.
    Muller, T.
    Olanow, C. W.
    Rascol, O.
    Russ, H.
    MOVEMENT DISORDERS, 2006, 21 : S606 - S607
  • [9] Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial
    Ondo, WG
    Fayle, R
    Atassi, F
    Jankovic, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (12): : 1636 - 1639
  • [10] Modafinil for the treatment of daytime sleepiness in Parkinson's disease:: A double-blind, randomized, crossover, placebo-controlled polygraphic trial
    Högl, B
    Saletu, M
    Brandauer, E
    Glatzl, S
    Frauscher, B
    Seppi, K
    Ulmer, H
    Wenning, G
    Poewe, W
    SLEEP, 2002, 25 (08): : 905 - 909
12345